1. Home
  2. |Insights
  3. |Mining Law Monitor - Volume 21, Issue 1 - (Spring 2004)

Mining Law Monitor - Volume 21, Issue 1 - (Spring 2004)

Client Alert | less than 1 min read | 04.28.04

  • "U.S. Supreme Court Rules in Bedroc v. United States: Ownership of Western Desert Sand and Gravel Shifts to Private Sector," Author: Tim McCrum.
  • "Subsidence in SMCRA § 522(e) Areas," Co-Authors: Tim Means and Michael Klise.
  • "Managing the High Risk of Regulatory Noncompliance," Author: Dick Bednar.
  • "Regulation of the Mining Industry — The Past is Prologue," Author: Ed Green.

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights